Immediate utility of two approved agents to target both the metabolic mevalonate pathway and its restorative feedback loop.

MLA

Pandyra, Aleksandra, et al. “Immediate Utility of Two Approved Agents to Target Both the Metabolic Mevalonate Pathway and Its Restorative Feedback Loop.” Cancer Research, vol. 74, no. 17, Sept. 2014, pp. 4772–82. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-14-0130.

APA

Pandyra, A., Mullen, P. J., Kalkat, M., Yu, R., Pong, J. T., Li, Z., Trudel, S., Lang, K. S., Minden, M. D., Schimmer, A. D., & Penn, L. Z. (2014). Immediate utility of two approved agents to target both the metabolic mevalonate pathway and its restorative feedback loop. Cancer Research, 74(17), 4772–4782. https://doi.org/10.1158/0008-5472.CAN-14-0130

Chicago

Pandyra, Aleksandra, Peter J Mullen, Manpreet Kalkat, Rosemary Yu, Janice T Pong, Zhihua Li, Suzanne Trudel, et al. 2014. “Immediate Utility of Two Approved Agents to Target Both the Metabolic Mevalonate Pathway and Its Restorative Feedback Loop.” Cancer Research 74 (17): 4772–82. doi:10.1158/0008-5472.CAN-14-0130.